Why Walgreen is Staying American and Paying Its Taxes

Walgreens buys Switzerland-based Alliance Boots, but decides not to move overseas in the process.

Aug 10, 2014 at 7:03AM

Source: Walgreens

Walgreen (NASDAQ:WBA) announced this week that it plans to buy the 55% of Switzerland-based Alliance Boots that it doesn't already own, but the American pharmacy isn't going to move overseas to lower its taxes as Wall Street had expected.

Investors are none too happy, sending shares down 14% on Wednesday.

Walgreen blamed the decision on an inability to structure a transaction with Alliance Boots that would allow it to move overseas. To undergo these so-called tax inversions, companies have to follow strict rules such as a certain percentage of the shareholders of the new company have to come from the foreign company. Management was clearly concerned with a protracted fight with the IRS.

But Walgreen hinted that the decision to stay in the U.S. was influenced by the potential for its business to suffer if it moved overseas.

"The company also was mindful of the ongoing public reaction to a potential inversion and Walgreen's unique role as an iconic American consumer retail company with a major portion of its revenues derived from government-funded reimbursement programs."

While you could certainly see a bit of an uproar if Walgreen moved overseas, I have a hard time seeing customers leaving for the long-term.

How many people avoid drinking Budweiser because it's no longer American? How about eating a Good Humor ice cream bar? Shopping at 7-Eleven? Feeding your baby Gerber-brand pureed carrots?

They're all owned by companies headquartered outside the U.S. Even John Hancock Life Insurance -- named after the guy who first signed the U.S. Declaration of Independence -- isn't even owned by a U.S. company .

Admittedly there's a difference between brands being bought by a foreign company and purposely moving overseas to avoid taxes. Maybe the bad press would have put a dent in business, especially when competitors, such as CVS Caremark (NYSE: CVS) are getting good press with its decision to stop selling cigarettes and tobacco products in its stores.

Government strikes back
While tax inversions are perfectly legal if all the rules are followed, President Obama isn't pleased that companies are moving overseas. Last month, Treasury Secretary Jacob J. Lew sent a letter to members of Congress urging them to "support legislative initiatives to reverse the trend toward corporate inversions."

With a divided congress and midterm elections approaching, passing that kind of legislation doesn't seem particularly likely.

Rather than push to stop tax inversions, the government could just discourage companies from moving overseas by not doing business with them. As Walgreen points out, "government-funded reimbursement programs" -- Medicare and Medicaid, for instance -- are a major portion of its business. If it wasn't allowed to participate in those programs the company would be sunk.

But it's hard to see how that type of legislation might be enacted given that there are plenty of foreign companies that provide useful services to Medicare and Medicaid. The largest generic-drug makers, Teva Pharmaceuticals (NYSE:TEVA), Novartis' (NYSE:NVS) Sandoz, and soon-to-be Mylan (NASDAQ:MYL), are all headquartered overseas. It's hard to see how the government could avoid doing business with them.

Perhaps the law could be structured to only include companies that have moved after a certain date. But even that runs into ethical issues. Imagine if a drug company with the only treatment available for a certain disease does a tax inversion. Is the government going to deny citizens the drug because it's not paying U.S. tax?

Chickened out
In the end, it seems Walgreen just decided the risks -- legality of the transaction, potential IRS troubles, damage to reputation, and political backlash -- didn't justify the reward of lower taxes. Management arguably chickened out, but being conservative isn't necessarily the worst trait to have in management.

Walgreen looks like a decent investment at this knocked down price, with a solid 1.7% dividend yield and some global growth prospects as it integrates Alliance Boots.

Even if it'll be paying a little more taxes than it could have.

Speaking of dividends
The smartest investors know that dividend stocks simply crush their non-dividend paying counterparts over the long term. That's beyond dispute. They also know that a well-constructed dividend portfolio creates wealth steadily, while still allowing you to sleep like a baby. Knowing how valuable such a portfolio might be, our top analysts put together a report on a group of high-yielding stocks that should be in any income investor's portfolio. To see our free report on these stocks, just click here now.

Brian Orelli has no position in any stocks mentioned. The Motley Fool recommends Teva Pharmaceutical Industries. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

4 in 5 Americans Are Ignoring Buffett's Warning

Don't be one of them.

Jun 12, 2015 at 5:01PM

Admitting fear is difficult.

So you can imagine how shocked I was to find out Warren Buffett recently told a select number of investors about the cutting-edge technology that's keeping him awake at night.

This past May, The Motley Fool sent 8 of its best stock analysts to Omaha, Nebraska to attend the Berkshire Hathaway annual shareholder meeting. CEO Warren Buffett and Vice Chairman Charlie Munger fielded questions for nearly 6 hours.
The catch was: Attendees weren't allowed to record any of it. No audio. No video. 

Our team of analysts wrote down every single word Buffett and Munger uttered. Over 16,000 words. But only two words stood out to me as I read the detailed transcript of the event: "Real threat."

That's how Buffett responded when asked about this emerging market that is already expected to be worth more than $2 trillion in the U.S. alone. Google has already put some of its best engineers behind the technology powering this trend. 

The amazing thing is, while Buffett may be nervous, the rest of us can invest in this new industry BEFORE the old money realizes what hit them.

KPMG advises we're "on the cusp of revolutionary change" coming much "sooner than you think."

Even one legendary MIT professor had to recant his position that the technology was "beyond the capability of computer science." (He recently confessed to The Wall Street Journal that he's now a believer and amazed "how quickly this technology caught on.")

Yet according to one J.D. Power and Associates survey, only 1 in 5 Americans are even interested in this technology, much less ready to invest in it. Needless to say, you haven't missed your window of opportunity. 

Think about how many amazing technologies you've watched soar to new heights while you kick yourself thinking, "I knew about that technology before everyone was talking about it, but I just sat on my hands." 

Don't let that happen again. This time, it should be your family telling you, "I can't believe you knew about and invested in that technology so early on."

That's why I hope you take just a few minutes to access the exclusive research our team of analysts has put together on this industry and the one stock positioned to capitalize on this major shift.

Click here to learn about this incredible technology before Buffett stops being scared and starts buying!

David Hanson owns shares of Berkshire Hathaway and American Express. The Motley Fool recommends and owns shares of Berkshire Hathaway, Google, and Coca-Cola.We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

©1995-2014 The Motley Fool. All rights reserved. | Privacy/Legal Information